X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (50) 50
index medicus (50) 50
monoclonal-antibody kw-0761 (43) 43
kw-0761 (41) 41
leukemia-lymphoma (38) 38
mogamulizumab (37) 37
oncology (36) 36
hematology (31) 31
leukemia (28) 28
female (27) 27
middle aged (27) 27
t cells (27) 27
leukemia/lymphoma (26) 26
male (25) 25
lymphomas (24) 24
leukemia-lymphoma, adult t-cell - drug therapy (23) 23
cancer (22) 22
aged (21) 21
antibodies, monoclonal, humanized - therapeutic use (21) 21
ccr4 (21) 21
chemotherapy (21) 21
expression (20) 20
lymphoma (20) 20
transplantation (20) 20
monoclonal antibodies (19) 19
multicenter phase-ii (17) 17
adult (16) 16
prognosis (16) 16
antibodies, monoclonal, humanized - adverse effects (14) 14
pharmacology & pharmacy (14) 14
anti-ccr4 antibody (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
immunology (11) 11
medicine & public health (11) 11
receptors, ccr4 - antagonists & inhibitors (11) 11
aged, 80 and over (10) 10
hemic and lymphatic diseases (10) 10
virus type-i (10) 10
adult t-cell leukemia/lymphoma (9) 9
antibodies, monoclonal, humanized - administration & dosage (9) 9
antibody (9) 9
immunotherapy (9) 9
lymphocytes (9) 9
phase-ii (9) 9
receptors, ccr4 - immunology (9) 9
animals (8) 8
antibodies, monoclonal, humanized - pharmacology (8) 8
care and treatment (8) 8
cc chemokine receptor 4 (8) 8
chemokine (8) 8
htlv-1 (8) 8
leukemia-lymphoma, adult t-cell - pathology (8) 8
non-hodgkin's lymphomas (8) 8
treatment outcome (8) 8
analysis (7) 7
anti-ccr4 monoclonal-antibody (7) 7
disease (7) 7
hematopoietic stem cells (7) 7
interferon-alpha (7) 7
leukemia-lymphoma, adult t-cell - mortality (7) 7
lymphoma, t-cell, peripheral - drug therapy (7) 7
receptor 4 antibody (7) 7
adult t-cell leukemia (6) 6
adult t-cell leukemia-lymphoma (6) 6
antineoplastic agents - therapeutic use (6) 6
atl (6) 6
immune system diseases (6) 6
infection (6) 6
leukemia-lymphoma, adult t-cell - immunology (6) 6
lymphocytes t (6) 6
medical prognosis (6) 6
retrospective studies (6) 6
sezary-syndrome (6) 6
skin (6) 6
survival (6) 6
therapy (6) 6
versus-host-disease (6) 6
antigens (5) 5
antineoplastic agents - pharmacology (5) 5
association (5) 5
chemokine receptor 4 (5) 5
flow cytometry (5) 5
leukemia-lymphoma, adult t-cell - therapy (5) 5
mice (5) 5
mycosis fungoides (5) 5
patients (5) 5
prognostic index (5) 5
receptors, ccr4 - genetics (5) 5
receptors, ccr4 - metabolism (5) 5
research (5) 5
stem cell transplantation (5) 5
stem cells (5) 5
antibodies (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
cell leukemia-lymphoma (4) 4
clinical trials as topic (4) 4
combination (4) 4
combination chemotherapy (4) 4
cutaneous t-cell lymphoma (4) 4
cytotoxicity (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CANCER SCIENCE, ISSN 1349-7006, 05/2013, Volume 104, Issue 5, pp. 647 - 650
We report an adult T-cell leukemia/lymphoma patient suffering from StevensJohnson Syndrome (SJS) during mogamulizumab (humanized anti-CCR4 monoclonal antibody)... 
LEUKEMIA-LYMPHOMA | ONCOLOGY | MONOCLONAL-ANTIBODY KW-0761 | TOXIC EPIDERMAL NECROLYSIS | CCR4
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 02/2019, Volume 180, Issue 2, pp. 419 - 420
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2019, Volume 25, Issue 14, pp. 4388 - 4399
Purpose: The anti-CCR4 mAb, mogamulizumab, offers therapeutic benefit to patients with adult T-cell leukemialymphoma (ATL), but skin-related adverse events... 
IMMUNE DYSREGULATION | MOLECULAR TARGET | ENTEROPATHY | ONCOLOGY | IMMUNOTHERAPY | LINKED SYNDROME IPEX | MONOCLONAL-ANTIBODY KW-0761 | POLYENDOCRINOPATHY | AUTOREACTIVE B-CELLS | CCR4 | ANTI-CCR4
Journal Article
Haematologica, ISSN 0390-6078, 05/2019, Volume 104, Issue 5, pp. 993 - 1003
Mogamulizumab, a humanized defucosylated anti-C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine... 
LEUKEMIA-LYMPHOMA | REVEALS MARKED ACTIVITY | LENALIDOMIDE | RETROVIRUS | MONOCLONAL-ANTIBODY KW-0761 | PHASE-II | JAPANESE | PRALATREXATE | HEMATOLOGY | EXPRESSION | TRANSPLANTATION
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 09/2016, Volume 22, Issue 17, pp. 4405 - 4416
Purpose: Mogamulizumab (Mog), a humanized anti-CC chemokine receptor 4 (CCR4) mAb that mediates antibody-dependent cellular cytotoxicity (ADCC) using Fc gamma... 
NATURAL-KILLER-CELLS | ACTIVATION | VIVO | ONCOLOGY | IMMUNOTHERAPY | FC-GAMMA-RIIIA | MONOCLONAL-ANTIBODY KW-0761 | LYMPHOMA | CD16 | COMBINATION | TRANSPLANTATION
Journal Article
JOURNAL OF IMMUNOLOGY, ISSN 0022-1767, 07/2013, Volume 191, Issue 1, pp. 135 - 144
We expanded human T-lymphotropic virus type 1 Tax-specific CTL in vitro from PBMC of three individual adult T cell leukemia/lymphoma (ATL) patients and... 
LEUKEMIA-LYMPHOMA | MOLECULAR TARGET | GENE | HEMATOPOIETIC STEM-CELL | MONOCLONAL-ANTIBODY KW-0761 | MICE | IMMUNOLOGY | CANCER | ADOPTIVE IMMUNOTHERAPY | TUMOR-IMMUNITY
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 5, pp. 672 - 682
This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐ CC chemokine receptor 4... 
mogamulizumab | study | CCR | randomized phase | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | CCR4 | Randomized phase II study | randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
CLINICAL JOURNAL OF ONCOLOGY NURSING, ISSN 1092-1095, 08/2019, Volume 23, Issue 4, pp. E73 - E80
BACKGROUND: Cutaneous T-cell lymphoma (CTCL), including subtypes mycosis fungoides (MF) and Sezary syndrome (SS), represents a rare group of non-Hodgkin... 
UNITED-STATES | mogamulizumab | NURSING | MYCOSIS-FUNGOIDES | adverse events | SEZARY-SYNDROME | mycosis fungoides | CONSORTIUM | Sezary syndrome | CCR4 EXPRESSION | ONCOLOGY | KW-0761 | LEUKEMIA
Journal Article
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 02/2019, Volume 49, Issue 2, pp. 153 - 159
None of the 15 patients with adult T-cell leukaemia/lymphoma developed Grade ≥3 radiation-induced dermatitis during a total of 46 courses of moderate-dose... 
LEUKEMIA-LYMPHOMA | CRITERIA | RECEPTOR 4 ANTIBODY | mogamulizumab | leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | CLASSIFICATION | TOXICITY | THERAPY | ONCOLOGY | radiodermatitis | radiotherapy | SURFACE | adult T cell | LEUKEMIA/LYMPHOMA | EXPRESSION
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 28, pp. 3426 - 3433
Journal Article